[1]
Mohamed Rahouma et al. 2021. Cardiothoracic Related Complications of Anti-PD/PD-L1 Immunotherapy. Recent Developments in Medicine and Medical Research Vol. 7. (Oct. 2021), 1–16. DOI:https://doi.org/10.9734/bpi/rdmmr/v7/8497D.